Eli Lilly wins US approval for new depression drug
Key points
- Eli Lilly & Co. on Wednesday said U.S. regulators have approved its new antidepressant, Cymbalta, a drug that analysts say will be central to the company's growth.
- Lilly's shares rose 2 percent to $64.50 in electronic pre-market trading.
- Food and Drug Administration said the highly anticipated drug is both safe and effective in treating major depression, the company reported in a statement.
- Industry analysts expect Cymbalta (duloxetine) to generate peak annual sales of $2 billion, a much-needed boon for Lilly after sales of its former top-selling antidepressant, Prozac, plummeted in the face of generic competition.
Eli Lilly & Co. on Wednesday said U.S. regulators have approved its new antidepressant, Cymbalta, a drug that analysts say will be central to the company's growth.
Lilly's shares rose 2 percent to $64.50 in electronic pre-market trading.
The U.S. Food and Drug Administration said the highly anticipated drug is both safe and effective in treating major depression, the company reported in a statement.
Industry analysts expect Cymbalta (duloxetine) to generate peak annual sales of $2 billion, a much-needed boon for Lilly after sales of its former top-selling antidepressant, Prozac, plummeted in the face of generic competition.
Cymbalta works by maximizing the presence in the brain of two chemicals, serotonin and norepinephrine. In this respect, it is similar to Wyeth's Effexor XR. Drugs like Prozac, Pfizer Inc.'s Zoloft and GlaxoSmithKline Plc's Paxil maximize the presence only of serotonin.
Cymbalta comes to the market at a time of growing uncertainty about new classes of antidepressants. Cymbalta came under scrutiny in February following the suicide of a 19-year-old college student involved in one of the company's clinical trials. She was not depressed at the beginning of the trial.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsAbortion drug may be useful for severe depression
A short course of mifepristone - better known as the abortion drug RU486 - leads to significant improvement in patients with major depressive episodes with psychotic features, according to new study findings. In many…
18 June 2005
NewsStudy says acne drug does not cause depression
A popular acne-fighting drug that has been linked to birth defects and is being monitored for ties to suicide did not cause depression in a group of adolescents, a study has found. Roche's Accutane, which is also sold…
17 May 2005
NewsTherapy said to be as good as drugs for some depression
Psychological therapy and counseling can be just as effective as drugs in the early stages of treating moderate to severe depression , a study released on Monday found, contrary to current practice. "On the whole, these…
